🌍·3h agoIndustry
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
Publisher
R
Relmada Therapeutics
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on relmada.com
Leave the platform to read the original full article on the publisher site.
Source: Relmada Therapeutics
Scope: Industry
Related coverage
More related coverage
Alloy Therapeutics·12h ago
Alloy Therapeutics and Institute for Protein Innovation Announce Strategic Collaboration to Advance Next-Generation Antibody Discovery
Cellectis·17h ago
Cellectis to Report First Quarter Financial Results on May 11, 2026
Orchestra BioMed·4d ago
Strengthening AVIM Therapy’s Regulatory Pathway: A Second FDA Breakthrough Device Designation
Aptose Biosciences·5d ago